Literature DB >> 24456892

Clinicopathological features in young patients treated for small-cell lung cancer: significance of immunohistological and molecular analyses.

Tomoko Katsui Taniyama1, Hiroshi Nokihara2, Koji Tsuta3, Hidehito Horinouchi1, Shintaro Kanda1, Yutaka Fujiwara1, Noboru Yamamoto1, Fumiaki Koizumi4, Mayu Yunokawa5, Tomohide Tamura1.   

Abstract

BACKGROUND: Small-cell lung cancer in young patients is very rare and has not been adequately described. In addition, malignancies associated with genetic rearrangements of nuclear protein of the testis (NUT) have been reported in young patients. PATIENTS AND METHODS: We reviewed the clinical records of patients younger than 40 years of age who had been diagnosed as having SCLC and had been treated for this condition. We also examined NUT rearrangements using immunohistochemistry (IHC) staining and fluorescence in situ hybridization (FISH) analysis.
RESULTS: We evaluated the diagnoses and treatment outcomes of 8 young patients among 747 SCLC patients. Based on further analyses using IHC staining and FISH, NUT rearrangements were found in 2 of these cases. The range of the overall survival period was 3.6 to 49.7 months. The 2 patients with NUT rearrangements survived for less than 12 months.
CONCLUSION: NUT rearrangements were identified in 2 patients who had been previously diagnosed as having SCLC. Further attention regarding the diagnosis of SCLC in young patients is needed.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Chemotherapy; FISH; IHC; NUT midline carcinoma; NUT rearrangements

Mesh:

Substances:

Year:  2013        PMID: 24456892     DOI: 10.1016/j.cllc.2013.06.012

Source DB:  PubMed          Journal:  Clin Lung Cancer        ISSN: 1525-7304            Impact factor:   4.785


  4 in total

1.  Primary Pulmonary NUT Midline Carcinoma: Clinical, Radiographic, and Pathologic Characterizations.

Authors:  Lynette M Sholl; Mizuki Nishino; Saraswati Pokharel; Mari Mino-Kenudson; Christopher A French; Pasi A Janne; Christopher Lathan
Journal:  J Thorac Oncol       Date:  2015-06       Impact factor: 15.609

2.  Functional linkage of gene fusions to cancer cell fitness assessed by pharmacological and CRISPR-Cas9 screening.

Authors:  Gabriele Picco; Elisabeth D Chen; Luz Garcia Alonso; Fiona M Behan; Emanuel Gonçalves; Graham Bignell; Angela Matchan; Beiyuan Fu; Ruby Banerjee; Elizabeth Anderson; Adam Butler; Cyril H Benes; Ultan McDermott; David Dow; Francesco Iorio; Euan Stronach; Fengtang Yang; Kosuke Yusa; Julio Saez-Rodriguez; Mathew J Garnett
Journal:  Nat Commun       Date:  2019-05-16       Impact factor: 14.919

3.  NUT expression in primary lung tumours.

Authors:  Marius Lund-Iversen; Krystyna Kotanska Grøholt; Åslaug Helland; Elin Borgen; Odd Terje Brustugun
Journal:  Diagn Pathol       Date:  2015-09-05       Impact factor: 2.644

4.  P63-negative pulmonary NUT carcinoma arising in the elderly: a case report.

Authors:  Satoe Numakura; Koji Saito; Noriko Motoi; Taisuke Mori; Yuichi Saito; Fumi Yokote; Yasuyuki Kanamoto; Momoko Asami; Takashi Sakai; Yoshikane Yamauchi; Yukinori Sakao; Hiroshi Uozaki; Masafumi Kawamura
Journal:  Diagn Pathol       Date:  2020-11-11       Impact factor: 2.644

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.